Keynote Presentation: Engineering of the Immune System
- Advancing Chimeric Antigen Receptor T-cell therapies: lessons learned from ex vivo engineered CAR T cell products
- Paving the way to in vivo generation of CAR-expressing immune cells: experience to date including viral and RNA-LNP based approaches
- The future of immunotherapy: bringing together precision medicine and nanotechnologies to advance safe, potent and tunable treatments for a broad range of disease categories